Current Drug Targets

2.5(top 20%)

impact factor

2.9K(top 10%)

papers

89.6K(top 5%)

citations

119(top 5%)

h-index

2.5(top 20%)

impact factor

3.3K

all documents

94.2K

doc citations

169(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	The Targets of Curcumin	Current Drug Targets	2011	613
2	Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design	Current Drug Targets	2010	528
3	Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue	Current Drug Targets	2013	481
4	NF-κB Signaling: Multiple Angles to Target OA	Current Drug Targets	2010	478
5	Cytochrome P450 Structure, Function and Clinical Significance: A Review	Current Drug Targets	2018	467
6	Complex Interactions between Phytochemicals. The Multi-Target Therapeutic Concept of Phytotherapy	Current Drug Targets	2011	390
7	Ginkgo Biloba Extract (EGb 761) and CNS Functions Basic Studies and Clinical Applications	Current Drug Targets	2000	384
8	Safety of Nanoparticles in Medicine	Current Drug Targets	2015	384
9	Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer	Current Drug Targets	2006	345
10	Glycogen Synthase Kinase-3 (GSK3) in Psychiatric Diseases and Therapeutic Interventions	Current Drug Targets	2006	339
11	Pharmacological Strategies for Overcoming Multidrug Resistance	Current Drug Targets	2006	335
12	Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy	Current Drug Targets	2010	318
13	Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach	Current Drug Targets	2011	305
14	Targeting SphK1 as a New Strategy against Cancer	Current Drug Targets	2008	294
15	Vitamin D: Evolutionary, Physiological and Health Perspectives	Current Drug Targets	2011	273
16	The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness	Current Drug Targets	2010	271
17	The ErbB Receptors and their Ligands in Cancer: An Overview	Current Drug Targets	2005	257
18	Current Research on Opioid Receptor Function	Current Drug Targets	2012	254
19	Glycogen Synthase Kinase-3 - An Overview of An Over-Achieving Protein Kinase	Current Drug Targets	2006	253
20	The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research	Current Drug Targets	2017	251
21	Acute and Chronic Stress-Induced Disturbances of Microglial Plasticity, Phenotype and Function	Current Drug Targets	2013	248
22	Integrin αvβ3 as a Therapeutic Target for Blocking Tumor-Induced Angiogenesis	Current Drug Targets	2003	246
23	Serotonergic Drugs for Depression and Beyond	Current Drug Targets	2013	246
24	Molecular Docking: Challenges, Advances and its Use in Drug Discovery Perspective	Current Drug Targets	2019	246
25	Molecular Pharmacology and Pharmacogenomics of Artemisinin and its Derivatives in Cancer Cells	Current Drug Targets	2006	243
26	Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation	Current Drug Targets	2015	238
27	Host-Pathogen Interactions Made Transparent with the Zebrafish Model	Current Drug Targets	2011	232
28	Perspectives on Sesquiterpene Lactones in Inflammation and Cancer	Current Drug Targets	2011	231
29	ROS-Mediated DNA Methylation Pattern Alterations in Carcinogenesis	Current Drug Targets	2015	228
30	Drug Delivery Systems: Past, Present, and Future	Current Drug Targets	2004	225
31	Heme Oxygenase-1 in Tumor Biology and Therapy	Current Drug Targets	2010	224
32	Structure, Pharmacology and Therapeutic Prospects of Family C G-Protein Coupled Receptors	Current Drug Targets	2007	222
33	The Functions and Structure of ABC Transporters: Implications for the Design of New Inhibitors of Pgp and MRP1 to Control Multidrug Resistance (MDR)	Current Drug Targets	2006	217
34	Cytokines in Neuroinflammation and Alzheimers Disease	Current Drug Targets	2004	216
35	Vascular Endothelial Growth Factor and Diabetic Retinopathy: Role of Oxidative Stress	Current Drug Targets	2005	212
36	Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities	Current Drug Targets	2014	209
37	Systemic Fungal Infections Caused by Candida Species: Epidemiology, Infection Process and Virulence Attributes	Current Drug Targets	2005	208
38	Accuracy of 25-Hydroxyvitamin D Assays: Confronting the Issues	Current Drug Targets	2011	205
39	MicroRNA-21: From Cancer to Cardiovascular Disease	Current Drug Targets	2010	204
40	Aldose Reductase, Still a Compelling Target for Diabetic Neuropathy	Current Drug Targets	2008	202
41	Improving Cancer Chemotherapy with Modulators of ABC Drug Transporters	Current Drug Targets	2011	199
42	A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimers Disease	Current Drug Targets	2003	198
43	The “Classical” Ovalbumin Challenge Model of Asthma in Mice	Current Drug Targets	2008	198
44	Serotonin (5-HT) Drugs: Effects on Appetite Expression and Use for the Treatment of Obesity	Current Drug Targets	2005	194
45	Therapeutic Targeting of Cancers with Loss of PTEN Function	Current Drug Targets	2014	194
46	Systemic Fungal Infections Caused by Aspergillus Species: Epidemiology, Infection Process and Virulence Determinants	Current Drug Targets	2005	193
47	Targeting Heme Oxygenase-1 for Neuroprotection and Neuroinflammation in Neurodegenerative Diseases	Current Drug Targets	2010	192
48	Serotonin Transporter Gene Variants and Behavior: A Comprehensive Review	Current Drug Targets	2006	190
49	Defining the Role of Integrin αvβ6 in Cancer	Current Drug Targets	2009	186
50	The Ubiquitin-Dependent Proteolytic System and other Potential Targets for the Modulation of Nuclear Factor-kB (NF-kB)	Current Drug Targets	2000	184

Scientometrics

Overviews

Citing Bodies

Current Drug Targets

Top Articles